McKesson Corporation vs Energy Select Sector SPDR Fund — how do they compare? McKesson Corporation trades at $930.02 (market cap $108.46B), while Energy Select Sector SPDR Fund trades at $65.66 (market cap $40.84B). The key difference: McKesson Corporation is far larger — about 2.7× Energy Select Sector SPDR Fund's market cap, and McKesson Corporation pays a 0.4% dividend while Energy Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and Energy Select Sector SPDR Fund for 67 Days on average.
| MCK | XLE | |
|---|---|---|
Market Cap | $108.46B | $40.84B |
Volume | 712,607 | 50,409,268 |
Sector | Health | — |
52-Week High | $995.69 | $65.93 |
52-Week Low | $725.17 | $42.61 |
Typical Hold Time | 74 Days | 67 Days |
Enterprise Value | $115.00B | — |
Dividend Yield | 0.4% | — |
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $910.33, down 1.23% over 24 hours, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue grew to $359.05 billion in 2025, though net margins remain thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing growth visibility in pharmaceutical distribution.
The outlook remains positive given analyst consensus favoring Buy ratings (80.65%) and a price target of $956.43, implying ~5% upside. Risks include margin pressure from drug pricing dynamics and policy uncertainty, while institutional accumulation and solid cash flow generation support stability. Earnings momentum and strategic partnerships position MCK for sustained growth, though investors should monitor competitive and regulatory headwinds.
XLE (Energy Select Sector SPDR ETF) trades at $65.46, up 3.28% with strong bullish momentum from moving averages but overbought RSI signals. The ETF faces mixed sentiment as oil prices surge above $100 amid Middle East tensions while futures traders bet on a 12% energy sector decline. Recent news highlights strategic oil reserve concerns and diesel price pressures, creating volatility in energy markets.
Outlook remains volatile with geopolitical risks and Fed policy influencing energy prices. The ETF's 91% oil and gas concentration offers pure energy exposure but amplifies crude price sensitivity. Key risks include oil price reversals and export restrictions, while institutional flows into midstream ETFs suggest defensive positioning within the sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →